ANDROSTA-1,4-DIENE-17-CARBOTHIOIC ACID, 6,9-DIFLUORO-11-HYDROXY-16-METHYL-17-(((3-METHYL-2-FURANYL)CARBONYL)OXY)-3-OXO-, S-(FLUOROMETHYL) ESTER, (6.ALPHA.,11.BETA.,16.ALPHA.,17.ALPHA.)-
UNII 9V85237XQG
Substance Identification & Data
This profile provides standardized clinical and technical data for Androsta-1,4-diene-17-carbothioic Acid, 6,9-difluoro-11-hydroxy-16-methyl-17-(((3-methyl-2-furanyl)carbonyl)oxy)-3-oxo-, S-(fluoromethyl) Ester, (6.alpha.,11.beta.,16.alpha.,17.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9V85237XQG.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 398455-10-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C28H31F3O6S NEGQCCIPPCOAFZ-HFYPQKGZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Androsta-1,4-diene-17-carbothioic Acid, 6,9-difluoro-11-hydroxy-16-methyl-17-(((3-methyl-2-furanyl)carbonyl)oxy)-3-oxo-, S-(fluoromethyl) Ester, (6.alpha.,11.beta.,16.alpha.,17.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.